Singapore Continues to Attract Top Scientific Talents

Agency for Science, Technology and Research and EDB Singapore
2007-05-09 12:33 872

Offers Investigatorship Awards up to US$500,000 to Outstanding Young Scientists of all Nationalities to Undertake Independent Research in Singapore

BOSTON, May 9 /Xinhua-PRNewswire/ -- Singapore continues to thrive as a vibrant location for scientific talent. Significant efforts and resources have been committed to attract and develop talent. Singapore adopts a pro-international and pro-local approach. A dynamic research environment, robust ethical framework, strict laws for the protection of intellectual property rights (Note 1) and quality of life, are some of the key reasons why a growing number of scientists are drawn to Singapore.

Note 1: Singapore cited as the best location in Asia for the protection of

intellectual property rights. (Source: The International Property

Rights Index (2007))

Over the past five years, Singapore has attracted an impressive list of internationally prominent scientists to lead the nation's biomedical sciences research and development efforts. (Please refer to Annex A for a list of distinguished scientists in Singapore.)

In continuing its efforts to attract talent, Singapore's Agency for Science, Technology & Research (A*STAR) launched A*STAR Investigatorships, a prestigious competitive award aimed at young international postdoctoral fellows who have demonstrated strong ability and creativity in research. Recipients of the award will be given an independent position at one of A*STAR's research institutes and can receive funding of up to US$500,000 per year.

"We invite and encourage the best young scientists of all nationalities to carry out cutting-edge research in Singapore. Recipients of A*STAR Investigatorships will enjoy generous funding, excellent facilities and infrastructure at Biopolis, as well as have the opportunity to be mentored by some of the world's most highly regarded biomedical researchers," said Dr. Andre Wan, Deputy Executive Director, Biomedical Research Council, A*STAR.

This year's call for proposals is in the areas of molecular and cell biology, genetics and genomics research relevant to human diseases and health. Applications are open and the deadline for submission is 31 May 2007.


A*STAR investigators will join a vibrant and rapidly growing community of more than 900 scientists and postdoctoral fellows from over 50 countries at the Biopolis, Singapore's premier biomedical research hub.

Partnerships and Collaborations

A*STAR is well connected to the international biomedical research community. Scientists at the institutes work closely with partners in the U.S. (e.g. UCSD, UIUC, UWash, MIT, Fred Hutch CRC), Europe (e.g. Karolinska Institute, Imperial College, Cambridge University, Dundee University, French Atomic Energy Commission) and Australasia (e.g. Australian National University, RIKEN in Japan) on research projects, collaborations and PhD training programs. A*STAR also hosts key international scientific conferences (e.g. Keystone, European Molecular Biology Organization, American Association for Cancer Research) and visits by distinguished scientists including many Nobel laureates.

The National University of Singapore (NUS) and Nanyang Technological University have also been successfully forging international partnerships. Duke University and NUS set up a Graduate Medical School (GMS) in Singapore to nurture clinician-scientists. The GMS will accept its first batch of students in August 2007 and will be awarding joint MD degrees from Duke and NUS.

Translational and Clinical Research

A*STAR works closely with the National Medical Research Council of the Singapore Ministry of Health to develop and strengthen research collaborations and programs between scientists at the Biopolis and the clinical community in hospitals and disease centers. The aim is to translate basic scientific discoveries and innovative technologies into potential therapies and diagnostics that will be applicable to major health conditions such as cancer, cardiovascular diseases, neurological disorders, infectious diseases and eye diseases.

"The scientists of today are incredibly mobile. They can choose to work anywhere in the world. Those who have selected Singapore have told us it is due to a combination of three reasons: steady funding, good facilities and exciting colleagues. We hope the A*STAR Investigatorships will extend this winning combination to the next generation of scientific leaders and persuade them to consider building their careers in Singapore," said Dr. Wan.

To obtain more information, please visit the Singapore Pavilion at booth number 2533.




Name From Designation in Other information


Alex Matter (Dr.) Novartis Director, Novartis Led the

Institute for development of

Tropical Diseases Gleevec,

Novartis' cancer


blockbuster drug.

Alan Colman (Dr.) U.K.-based PPL Chief Executive Well known for his

Therapeutics, a Officer, ES Cell work with the

spin-off from the International Roslin Institute

Roslin Institute to clone Dolly the


Scientific Leaders at A*STAR's Biomedical Research Council

Name From Designation in Other information


Sydney Brenner Salk Institute -- Scientific 2002 Nobel prize

(Dr.) of Biological Advisor to in Physiology or

Studies Chairman, Medicine for

A*STAR establishing C.

-- Chairman, elegans as a novel

Biomedical experimental

Research model organism to

Council link genetic

analysis to cell



and organ


David Lane University of -- Executive One of the

(Dr. Sir) Dundee Deputy Chairman, scientists

Biomedical credited with

Sciences and the landmark

Technology, discovery of the

Biomedical cancer gene p53.

Research Founder of

Council Cyclacel, a

-- Executive Scottish biotech

Director, company.

Institute of

Molecular and

Cell Biology

-- Chief Executive





Edward Holmes University of -- Executive Expert on

(Dr.) California San Deputy Chairman, translational

Diego Clinical- research and

Translational academic medicine.





-- Executive






Ministry of


Research Institutes

Name From Designation in Other information


Edison Liu(Dr.) National Cancer Executive Expert on breast

Institute Director, Genome cancer research.

Institute of


Jackie Ying(Dr.) Massachusetts Executive Expert on

Institute of Director, nanotechnology and

Technology Institute of its use in

Bioengineering & biotechnology,

Nanotechnology medical and

chemical sciences.

Judith Swain(Dr.) University of Executive Expert on creating

California San Director, models to

Diego Singapore understand the

Institute of genetic basis of

Clinical Sciences cardiovascular

development and


Neal Copeland & National Cancer Principal Renowned cancer

Nancy Jenkins Institute Investigators, geneticists who

(Drs.) Institute of are among the

Molecular and Cell world's most

Biology frequently-cited


Philip Ingham University of Principal Expert on

(Dr.) Sheffield Investigator, developmental

Institute of genetics

Molecular and and cell-to-cell

Cell Biology communication.

Jean Paul Thiery Institut Curie Principal Expert on cell

(Dr.) Investigator, adhesion and

Institute of migration studies.

Molecular and

Cell Biology

Yoshiaki Ito University of Principal Expert on RUNX

(Dr.) Kyoto Investigator, genes, a major

Institute of tumor suppressor

Molecular and associated with

Cell Biology gastric cancer.

and the


University of



Name From Designation in Other information


George Radda Department of Chairman, Expert on magnetic

(Dr.Sir) Physiology, Singapore resonance in

Anatomy and Bioimaging medicine.

Genetics, Consortium


of Oxford

Philippe College de Chairman, Expert on molecular

Kourilsky France Singapore immunology and

(Dr.) Immunology tumor immunity.


Roger Pedersen University of Chairman, Expert on stem

(Dr.) Cambridge Singapore Stem cell.



Axel Ullrich Oversees the Director, Founder of

(Dr.) molecular Singapore numerous biotech

biology OncoGenome companies

department, Project including Sugen

Max Planck and U3.



For media enquiries, please contact Ruder Finn.

Kim Hamelburg

Senior Associate

Ruder Finn Binder (Boston)

Tel: +1-781-559-0429

HP: +1-202-577-8227


Rae Chew

Senior Consultant

Ruder Finn Asia (Singapore)

HP: +65-9823-7722


Source: Agency for Science, Technology and Research and EDB Singapore